The evaluation of effect of herbal supplement (Melissa Officinalis and Hypericum perforatum along with DDW water) on the improvement of clinical symptoms, CD4 level and the viral load of HIV positive patients
Phase 3
Recruiting
- Conditions
- AIDS.Human immunodeficiency virus (HIV) disease
- Registration Number
- IRCT20210216050373N3
- Lead Sponsor
- Vice Chancellor of Research, Tehran University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Patients must give their knowing and voluntary written consent to join the study
Patients must have at least two positive ELISA HIV test results
Patients who have failed to benefit from anti-retroviral drugs due to drug resistance
Exclusion Criteria
Patients with undetectable levels of blood viral content
Patients with Hepatitis B or C
Pregnancy and lactation
Patients who have used immuno-enhancers; use of antibiotics and other prescribed medication to treat AIDS symptomology is excepted
Present use of illegal drugs or alcohol
Use of growth hormone 30 days prior to the study
Use of testosterone or anabolic steroids 30 days prior to the study
Chemotherapy, radiotherapy or interferon treatment 3 weeks prior to entering the study
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method HIVAb. Timepoint: AT the beginning and the ending of the study. Method of measurement: HIVAb ELISA.;CBC. Timepoint: At the beginning and the ending of the study. Method of measurement: Blood Test.;Viral Load. Timepoint: Beginning and the ending of the study. Method of measurement: PCR.
- Secondary Outcome Measures
Name Time Method AIDS-related clinical signs and drug interactions. Timepoint: Weekly during the course of the study. Method of measurement: Physician's examinations and phone calls in case of occurrence of sings and symptoms.